Search the MBS

• Previous - Note IN.0.4
• Next - Note IN.0.6

• Previous - Note IN.0.5
• Next - Note IN.0.7

• Previous - Note IN.0.14
• Next - Note IN.0.16

Related Items: 61333 61336 61341 61563 61564 61612

• Previous - Note IN.0.16
• Next - Note IN.0.18

• Previous - Note IN.4.4
• Next - Note IN.4.6

DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 2 COMPLEXITY where:

(a)    dosimetry for a two phase three dimensional conformal treatment plan using CT image volume dataset(s) with at least one gross tumour volume, two planning target volumes and one organ at risk defined in the prescription; or

(b)    dosimetry for a one phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, one planning target volume and two organ at risk dose goals or constraints defined in the prescription; or

(c)    image fusion with a secondary image (CT, MRI or PET) volume dataset used to define target and organ at risk volumes in conjunction with and as specified in dosimetry for three dimensional conformal radiotherapy of level 1 complexity.

All gross tumour targets, clinical targets, planning targets and organs at risk as defined in the prescription must be rendered as volumes. The organ at risk must be nominated as planning dose goals or constraints and the prescription must specify the organs at risk as dose goals or constraints. Dose volume histograms must be generated, approved and recorded with the plan. A CT image volume dataset must be used for the relevant region to be planned and treated. The CT images must be suitable for the generation of quality digitally reconstructed radiographic images

Fee: $916.10 Benefit: 75% = $687.10 85% = $822.90

(See para TN.2.3 of explanatory notes to this Category)

• Previous - Item 15556
• Next - Item 15562

DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 3 COMPLEXITY - where:

(a)    dosimetry for a three or more phase three dimensional conformal treatment plan using CT image volume dataset(s) with at least one gross tumour volume, three planning target volumes and one organ at risk defined in the prescription; or

(b)    dosimetry for a two phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, and

        (i) two planning target volumes; or

        (ii) two organ at risk dose goals or constraints defined in the prescription.

or

(c)    dosimetry for a one phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, one planning target volume and three organ at risk dose goals or constraints defined in the prescription;

or

(d)    image fusion with a secondary image (CT, MRI or PET) volume dataset used to define target and organ at risk volumes in conjunction with and as specified in dosimetry for three dimensional conformal radiotherapy of level 2 complexity.

All gross tumour targets, clinical targets, planning targets and organs at risk as defined in the prescription must be rendered as volumes. The organ at risk must be nominated as planning dose goals or constraints and the prescription must specify the organs at risk as dose goals or constraints. Dose volume histograms must be generated, approved and recorded with the plan. A CT image volume dataset must be used for the relevant region to be planned and treated. The CT images must be suitable for the generation of quality digitally reconstructed radiographic images

Fee: $1,184.85 Benefit: 75% = $888.65 85% = $1,091.65

(See para TN.2.3 of explanatory notes to this Category)

• Previous - Item 15559
• Next - Item 15565

Lung ventilation study using Galligas and lung perfusion study using gallium-68 macro aggregated albumin (⁶⁸Ga-MAA), with PET, if the service is performed because the service to which item 61348 applies cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive

Fee: $443.35 Benefit: 75% = $332.55 85% = $376.85

(See para IN.0.17 of explanatory notes to this Category)

• Previous - Item 61329
• Next - Item 61336

Cerebral study, with PET, if the service is performed because the service to which item 61402 applies cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive

Fee: $605.05 Benefit: 75% = $453.80 85% = $514.30

(See para IN.0.17 of explanatory notes to this Category)

• Previous - Item 61333
• Next - Item 61340

Bone study – whole body with PET, with delayed imaging when undertaken, if the service is performed because the services to which item 61421 or 61425 apply cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive

Fee: $600.70 Benefit: 75% = $450.55 85% = $510.60

(See para IN.0.17 of explanatory notes to this Category)

• Previous - Item 61340
• Next - Item 61345